A US House committee added an amendment to a must-pass appropriations bill that will give the FDA the legal authority to force drug makers to complete post-marketing studies of new drugs. The Pharmaceutical Research and Manufacturers of America argued that the agency already has "broad authority to monitor and ensure the safety of prescription drug products after approval." Diedtra Henderson, Boston Globe 05/11/2006 Read Article: Boston Globe Thursday, May 11, 2006
FDA May Have Power to Force Drug Makers to Complete Trials
A US House committee added an amendment to a must-pass appropriations bill that will give the FDA the legal authority to force drug makers to complete post-marketing studies of new drugs. The Pharmaceutical Research and Manufacturers of America argued that the agency already has "broad authority to monitor and ensure the safety of prescription drug products after approval." Diedtra Henderson, Boston Globe 05/11/2006 Read Article: Boston Globe 
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment